SYDNEY PAYNE: Open Payments
NPI 1730364209 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 26 payments from 9 companies in 2025. Trend: 2023 $542 · 2024 $376 · 2025 $439
Food & beverage: $439
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $179 |
| PFIZER INC. | 2 | $58 |
| ABBVIE INC. | 3 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Hologic Sales and Service, LLC | 1 | $27 |
| Astellas Pharma US Inc | 1 | $25 |
| Lilly USA, LLC | 1 | $24 |
| Dexcom, Inc. | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $17 |
Products named: Ozempic, NURTEC ODT, AIRSUPRA, Rybelsus, Wegovy, QULIPTA, APTIMA, Veozah.
Industry payments across TX — which companies pay providers there.
